Cardiac manifestations of COVID-19 in Shenzhen, China

JH Zeng, WB Wu, JX Qu, Y Wang, CF Dong, YF Luo… - Infection, 2020 - Springer
JH Zeng, WB Wu, JX Qu, Y Wang, CF Dong, YF Luo, D Zhou, WX Feng, C Feng
Infection, 2020Springer
Purpose The coronavirus disease 2019 (COVID-19) outbreak has become a global public
health concern; however, relatively few detailed reports of related cardiac injury are
available. The aims of this study were to compare the clinical and echocardiographic
characteristics of inpatients in the intensive-care unit (ICU) and non-ICU patients. Methods
We recruited 416 patients diagnosed with COVID-19 and divided them into two groups: ICU
(n= 35) and non-ICU (n= 381). Medical histories, laboratory findings, and echocardiography …
Purpose
The coronavirus disease 2019 (COVID-19) outbreak has become a global public health concern; however, relatively few detailed reports of related cardiac injury are available. The aims of this study were to compare the clinical and echocardiographic characteristics of inpatients in the intensive-care unit (ICU) and non-ICU patients.
Methods
We recruited 416 patients diagnosed with COVID-19 and divided them into two groups: ICU (n = 35) and non-ICU (n = 381). Medical histories, laboratory findings, and echocardiography data were compared.
Results
The levels of myocardial injury markers in ICU vs non-ICU patients were as follows: troponin I (0.029 ng/mL [0.007–0.063] vs 0.006 ng/mL [0.006–0.006]) and myoglobin (65.45 μg/L [39.77–130.57] vs 37.00 μg/L [26.40–53.54]). Echocardiographic findings included ventricular wall thickening (12 [39%] vs 1 [4%]), pulmonary hypertension (9 [29%] vs 0 [0%]), and reduced left-ventricular ejection fraction (5 [16%] vs 0 [0%]). Overall, 10% of the ICU patients presented with right heart enlargement, thickened right-ventricular wall, decreased right heart function, and pericardial effusion. Cardiac complications were more common in ICU patients, including acute cardiac injury (21 [60%] vs 13 [3%]) (including 2 cases of fulminant myocarditis), atrial or ventricular tachyarrhythmia (3 [9%] vs 3 [1%]), and acute heart failure (5 [14%] vs 0 [0%]).
Conclusion
Myocardial injury marker elevation, ventricular wall thickening, pulmonary artery hypertension, and cardiac complications including acute myocardial injury, arrhythmia, and acute heart failure are more common in ICU patients with COVID-19. Cardiac injury in COVID-19 patients may be related more to the systemic response after infection rather than direct damage by coronavirus.
Springer